JOHN SPENCE: Open Payments
NPI 1497794796 · MARIANNA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,261 in 117 payments from 18 companies in 2025. Trend: 2023 $2,383 · 2024 $2,339 · 2025 $2,261
Food & beverage: $2,261
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $472 |
| AstraZeneca Pharmaceuticals LP | 13 | $340 |
| ABBVIE INC. | 15 | $312 |
| PFIZER INC. | 9 | $189 |
| GlaxoSmithKline, LLC. | 11 | $179 |
| Amgen Inc. | 10 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $144 |
| Vanda Pharmaceuticals Inc. | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| Merck Sharp & Dohme LLC | 4 | $60 |
Products named: Ozempic, AIRSUPRA, NURTEC ODT, TRELEGY ELLIPTA, QULIPTA, CAPLYTA, Wegovy, VRAYLAR.
Industry payments across FL — which companies pay providers there.
